Eden Research (LON:EDEN) Stock Price Down 0.2% – What’s Next?

Shares of Eden Research plc (LON:EDEN) traded down 0.2% on Friday . The company traded as low as GBX 3.59 ($0.05) and last traded at GBX 3.59 ($0.05). 10,000 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 920,772 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 0.2 %

The company has a 50 day moving average price of GBX 3.88 and a 200-day moving average price of GBX 3.95. The stock has a market capitalization of £19.17 million, a PE ratio of -12.59 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42.

Insiders Place Their Bets

In other news, insider Lykele van der Broek bought 256,000 shares of the firm’s stock in a transaction dated Thursday, February 6th. The stock was purchased at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,975.16). Also, insider Alexander John Abrey bought 540,540 shares of the stock in a transaction dated Tuesday, January 28th. The stock was purchased at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,396.86). Company insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.